{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-092471","form_type":"8-K","ticker":"ESLA","cik":"0001844417","company_name":"Estrella Immunopharma, Inc.","filed_at":"2025-09-26T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.317271+00:00","generated_at":"2026-05-17T05:36:15.396751+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"medium","headline":"Estrella Immunopharma appoints Jia Dengyao to Board of Directors","bullets":["Board appointed Jia Dengyao as director effective September 22, 2025.","Mr. Jia has not been named to any Board committees as of the filing.","Company entered into standard indemnification agreement with new director.","Appointment adds a new independent voice but no other details provided."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-092471","json":"https://secwatch.observer/filing/0001213900-25-092471.json","markdown":"https://secwatch.observer/filing/0001213900-25-092471.md","text":"https://secwatch.observer/filing/0001213900-25-092471.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1844417/000121390025092471/0001213900-25-092471-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1844417/000121390025092471/ea0259031-8k_estrella.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T05:36:15.396751+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}